Skip to main content
. 2024 Mar 6;10:1289454. doi: 10.3389/fmed.2023.1289454

Table 3.

Crude and adjusted analysis of variables related to percent-predicted peak VO2 after COVID-19 hospitalization.

ppVO2 (%)
OR 95% CI p value
COVID-19 vs Controls
Unadjusted 0.92 0.88–0.97 0.003
Adjusteda 0.92 0.87–0.97 0.002
COVID-19
Age (years) 0.99 0.99–1.00 0.09
Male sex 0.94 0.87–1.02 0.15
BMI (kg/m2) 1.00 0.99–1.01 0.10
Hypertension 0.95 0.87–1.03 0.25
Diabetes 0.96 0.87–1.06 0.49
CAD 0.83 0.76–0.89 <0.001
Advanced oxygen support 0.91 0.79–1.04 0.20
-High flow cannula 0.94 0.76–1.16 0.57
-Bilevel 0.83 0.78–0.88 <0.001
-Mechanical ventilation 0.88 0.79–0.98 0.02
ICU admission 0.94 0.81–1.09 0.45
Hospital length of stay (days) 0.99 0.99–0.99 0.001
WHO COVID-19 Severe/Critical 0.89 0.80–1.00 0.06

Bilevel, bi-level positive airway pressure; BMI, body mass index; CAD, coronary artery disease; CI, confidence interval; CPAP, continuous positive airway pressure; CPET, cardiopulmonary exercise testing; ICU, intensive care unit; OR, odds ratio; ppVO2, predicted-percentage peak VO2; WHO, world health organization. Continuous data are presented as mean ± standard deviation or median (p25–p75).

a

Adjusted for age, sex, height, and weight.